Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
100 studies found for:    Open Studies | "Vasculitis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Vasculitis" (100 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Endothelin Antagonism in ANCA Vasculitis
Condition: Vasculitis
Intervention: Drug: BQ123 or BQ123/788
2 Recruiting Optical Coherence Tomography (OCT) in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
3 Recruiting IgA-positive Versus IgA-negative Immune Complex Vasculitis
Condition: Cutaneous Vasculitis
Intervention:
4 Recruiting MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS
Condition: ANCA-associated Vasculitis
Intervention: Other: Non interventional study
5 Recruiting Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Intervention: Drug: Rituximab
6 Recruiting Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Condition: ANCA-associated Primary Necrotizing Vasculitides
Interventions: Drug: Rosuvastatin;   Drug: Placebo
7 Recruiting Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
Conditions: Pneumococcal Infection;   ANCA-associated Vasculitis
Intervention:
8 Recruiting Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
Conditions: Cryoglobulinemia;   Systemic Vasculitis
Interventions: Drug: rituximab;   Drug: Prednisone;   Drug: Placebo
9 Not yet recruiting A Randomized Multicenter Study for Isolated Skin Vasculitis
Conditions: Primary Cutaneous Vasculitis;   Cutaneous Polyarteritis Nodosa;   IgA Vasculitis;   Henoch-Schönlein Purpura
Interventions: Drug: Colchicine;   Drug: Dapsone;   Drug: Azathioprine
10 Recruiting The Clinical Efficacy of DFPP in Patients With AAGN
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions: Other: DFPP&CTX;   Drug: CTX
11 Recruiting Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis
Conditions: Vasculitis;   Cryoglobulinemia;   Hepatitis C
Intervention: Drug: new antiviral therapy
12 Recruiting Low-dose Glucocorticoid Vasculitis Induction Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Drug: Rituximab;   Drug: Glucocorticoids
13 Not yet recruiting Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
Conditions: ANCA-associated Vasculitis;   Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   EosinphilicGranulomatosis With Polyangiitis
Intervention:
14 Recruiting Vasculitis Pregnancy Registry
Conditions: Vasculitis;   Behcet's Disease;   CNS Vasculitis;   Cryoglobulinemic Vasculitis;   Eosinophilic Granulomatosis With Polyangiitis (EGPA);   Churg-Strauss Syndrome (CSS);   Granulomatosis With Polyangiitis (GPA);   Wegener's Granulomatosis;   IgA Vasculitis;   Henoch-Schoenlein Purpura (HSP);   Microscopic Polyangiitis (MPA);   Polyarteritis Nodosa (PAN);   Takayasu Arteritis (TAK);   Urticarial Vasculitis;   Systemic Vasculitis
Intervention: Other: Online questionnaires
15 Recruiting Pediatric Vasculitis Initiative
Conditions: Wegeners Granulomatosis (Granulomatosis With Polyangiitis);   Microscopic Polyangiitis;   Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis);   Polyarteritis Nodosa;   Takayasu Arteritis;   Primary CNS Vasculitis;   Unclassified Vasculitis
Intervention:
16 Recruiting Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Conditions: Autoimmune Disease;   Vascular Disease
Intervention:
17 Not yet recruiting Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?
Conditions: Arthritis;   Vasculitis
Intervention:
18 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
19 Recruiting Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis
Conditions: Granulomatosis, Wegener's;   Microscopic Polyangiitis
Intervention: Other: blood specimen
20 Recruiting The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach
Conditions: Granulomatosis With Polyangiitis;   Wegener Granulomatosis;   Vasculitis
Interventions: Drug: 5 mg prednisone;   Drug: 0 mg prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.